Tavist (clemastine fumarate)
Company: Sandoz PharmaceuticalsApproval Status: Approved November 1996
Treatment for: cold symptoms, including sneezing and runny nose
Areas: Respiratory
Possible similar drugs: Tavist
General Information
Tavist-D has been approved for the treatment of cold symptoms, including sneezing and runny nose. The FDA decision results from well-controlled clinical studies of the antihistamine clemastive fumarate, the active ingredient that differentiates the Tavist product from others.
Tavist Drug Information
The Tavist drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.
